SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Labrador who wrote (1415)11/13/1998 9:05:00 AM
From: Mr. Miller  Read Replies (1) | Respond to of 2135
 
Bottom line. Publications are coming to substantiate their claims. You can't touch that. Getting data published in credible journals is the most solid thing to do here. It is equivalent to a ruling by the supreme court. It is solid as a rock, but not completely immune to change or refute. It is a permanent record. The WSJ is a dust collector/fire starter.

ENMD has a great future today and in the next 12 to 18 months.

Miller



To: Labrador who wrote (1415)11/13/1998 3:14:00 PM
From: zonkie  Respond to of 2135
 
>>>>>Interview -- Plus or Minus for ENMD?
what does the public think? <<<<<

I think the stock going down 7% in the 5 hours since the interview answers your question better than a poll.

zonkie....


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News